Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

diversity_graphic

Enough talk: Action is required to achieve parity in biotech

August 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, Women in pharma, diversity, feature, pharma, women

Liz Lewis, Chief Counsel & Head of Patient Advocacy at Takeda Oncology tackles the crucial and topical issue of diversity …

Feature
jazz_pharma

Jazz Pharmaceuticals to expand Irish workforce across Dublin, Athlone sites

August 6, 2018
Manufacturing and Production, Sales and Marketing Dublin, Ireland, jazz pharmaceuticals, pharma

Jazz Pharmaceuticals has announced its intention to expand its staff numbers at two of its bases in its home country …

News
armind_madan

England’s top GP resigns over imflammatory online comments

August 6, 2018
Medical Communications, Research and Development, Sales and Marketing Dr Armind Madan, England, GP, pharma

England’s most senior General Practitioner and Director of Primary Care and Deputy Medical Director at NHS England has resigned over …

News

Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation

August 3, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, pharma, signet chemical corporation

Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation Pvt. Ltd. for cGMP Quaternary Ammonium Compounds for …

News
Press release
allergan

Almirall picks up Allergan’s dermatology portfolio to for $650m

August 3, 2018
Medical Communications, Sales and Marketing Allergan, Almirall, dermatology, pharma

Allergan has sealed a deal to sell its dermatology portfolio, comprising five brands, to Spanish pharmaceutical firm Almirall for $650 …

News
shutterstock_212035546

Epizyme shuts down failing lymphoma trial as FDA imposes clinical hold

August 3, 2018
Medical Communications, Research and Development Epizyme, FDA, lymphoma, pharma, tazemetostat

Epizyme’s Q2 financial results have been derailed by the company’s decision to terminate further Phase 2 development of its lead …

News

Novartis hands over global rights for two oncology drugs to Shanghai’s Laekna

August 2, 2018
Sales and Marketing Cancer, Laekna, Novartis, oncology, pharma

Novartis has revealed that it has jettisoned two of its clinical stage oncology products along with exclusive global development and …

News
shutterstock_38078521

Two injured in chemical incident at Sanofi lab in Ireland

August 2, 2018
Manufacturing and Production Ireland, Sanofi, pharma

Two female employees have been injured in a chemical incident at a Sanofi lab at the company’s Waterford site in …

News
otsuka_web

Otsuka scores EU schizophrenia approval, but acute myeloid leukaemia drug flops at Phase 3

August 1, 2018
Research and Development, Sales and Marketing Astex, Otsuka, Rxulti, guadecitabine, pharma, schizophrenia

It’s bittersweet news for Otsuka as it emerges that the European Commission saw fit to approve its therapy Rxulti (brexpiprazole) …

News

Pfizer notches two EU approvals, including Herceptin biosimilar

August 1, 2018
Research and Development, Sales and Marketing Cancer, EMA, EU, Genetech, Herceptin, Pfizer, Trazimera, Xeljanz, biosimilar, breast cancer, pharma

Pfizer is patting itself on the back after securing two new approvals in Europe within 24 hours: Xeljanz (tofacitinib citrate) …

News
novartis_outside_1

Novartis migraine prevention drug scores EU approval

July 31, 2018
Manufacturing and Production, Sales and Marketing Aimovig, Europe, Novartis, migraine, pharma

Novartis is celebrating the news that its calcitonin gene-related peptide receptor (CGRP-R) pathway therapy Aimovig (erenumab) has been approved by …

News

Progenics’ Azedra becomes first FDA-approved treatment for adrenal tumours

July 31, 2018
Manufacturing and Production, Sales and Marketing Cancer, FDA, Progenics, adrenal cancer, pharma

The FDA has approved its first-ever drug for rare, unresectable tumours of the adrenal gland with its decision to authorise …

News
wockhardt_hospital_mumbai

Wockhardt launches $40m manufacturing plant in Dubai

July 30, 2018
Manufacturing and Production, Sales and Marketing Antibiotics, Dubai, India, Wockhardt, antibiotic resistance, pharma

Indian pharmaceutical firm Wockhardt has launched its first manufacturing facility in Dubai’s Jebel Ali Free Zone (Jafza). Costing $40 million, …

News
john-milligan-thumbnail-300x300

Gilead’s CEO and Chairman to both step down before year’s end

July 30, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …

Appointment

Living with Behçet’s disease

July 30, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Behçet's disease, patient experience, pharma

Suzanne Morris speaks to Pharmafocus to discuss her life with Behçet’s disease, a rare condition characterised by the inflammation of …

Feature
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026